Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole + Isoproterenol
|
DCBY3J2
|
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Allopurinol + Isoproterenol
|
DCUJA7C
|
Allopurinol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Aminosalicylic acid + Isoproterenol
|
DCHCKN9
|
Aminosalicylic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Armodafinil + Isoproterenol
|
DC7H6EH
|
Armodafinil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
AS-1949490 + Isoproterenol
|
DCLFKGC
|
AS-1949490
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
BIO-300 + Isoproterenol
|
DC3OVEB
|
BIO-300
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Brincidofovir + Isoproterenol
|
DCJ7RMX
|
Brincidofovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Chlorzoxazone + Isoproterenol
|
DCMNYR8
|
Chlorzoxazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Cisatracurium + Isoproterenol
|
DC8ADWM
|
Cisatracurium
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Cycloguanil + Isoproterenol
|
DC83MOF
|
Cycloguanil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Cytarabine + Isoproterenol
|
DCMDXA8
|
Cytarabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Darunavir + Isoproterenol
|
DCSTFDL
|
Darunavir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Diazoxide + Isoproterenol
|
DCZ7LBG
|
Diazoxide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Diphenidol + Isoproterenol
|
DCLO9B5
|
Diphenidol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Docetaxel + Isoproterenol
|
DCKTZ2Q
|
Docetaxel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Entacapone + Isoproterenol
|
DC72S5Q
|
Entacapone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Estramustine + Isoproterenol
|
DCEUDFM
|
Estramustine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
ETHISTERONE + Isoproterenol
|
DCU82SH
|
ETHISTERONE
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Etonogestrel + Isoproterenol
|
DC9I6R6
|
Etonogestrel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Fomepizole + Isoproterenol
|
DCMVFYJ
|
Fomepizole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Furazolidone + Isoproterenol
|
DCQLZ6N
|
Furazolidone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Galantamine + Isoproterenol
|
DC60L7C
|
Galantamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Kanamycin
|
DCNDTIB
|
Kanamycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Imipramine
|
DCA8JCV
|
Imipramine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Crotamiton
|
DC850O5
|
Crotamiton
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Methotrexate
|
DCSZJIN
|
Methotrexate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Repaglinide
|
DCF950S
|
Repaglinide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Testosterone
|
DCYZMAT
|
Testosterone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + IT-141
|
DCCJLEU
|
IT-141
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Ursodeoxycholic acid
|
DCKAKJF
|
Ursodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Sulfapyridine
|
DCH5VIU
|
Sulfapyridine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Tolvaptan
|
DCQKK7B
|
Tolvaptan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Arfolitixorin
|
DCG0IAX
|
Arfolitixorin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Trazodone
|
DCSR8H1
|
Trazodone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Trifluoperazine
|
DC56ANW
|
Trifluoperazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + GINKGOLIDE A
|
DCOZZPE
|
GINKGOLIDE A
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Imatinib
|
DCKYH61
|
Imatinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Trimethobenzamide
|
DC5PT4J
|
Trimethobenzamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Bumetanide
|
DCFXKJO
|
Bumetanide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Hyodeoxycholic acid
|
DCHOEOI
|
Hyodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Spironolactone
|
DCVE0JL
|
Spironolactone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Chlormezanone
|
DCPYQKA
|
Chlormezanone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Mycophenolic acid
|
DCIGMQG
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Hydralazine
|
DCEB38Z
|
Hydralazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Mefloquine
|
DCD2MY6
|
Mefloquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Auranofin
|
DCBKPNT
|
Auranofin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Vorinostat
|
DCY3RIH
|
Vorinostat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Isoproterenol + Aciclovir
|
DC26LCR
|
Aciclovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
L-165041 + Isoproterenol
|
DC12NZQ
|
L-165041
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Lacosamide + Isoproterenol
|
DCDY2PP
|
Lacosamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Maprotiline + Isoproterenol
|
DC0OOCT
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Mebendazole + Isoproterenol
|
DCMZYAN
|
Mebendazole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Mesalazine + Isoproterenol
|
DCCGLLY
|
Mesalazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Methoxsalen + Isoproterenol
|
DCRSHYA
|
Methoxsalen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Metyrosine + Isoproterenol
|
DC44SVW
|
Metyrosine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Naltrexone + Isoproterenol
|
DCKA08Y
|
Naltrexone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Olmesartan medoxomil + Isoproterenol
|
DCCDCBH
|
Olmesartan medoxomil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Oseltamivir + Isoproterenol
|
DCWI4OO
|
Oseltamivir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Pargyline + Isoproterenol
|
DCEHXCS
|
Pargyline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Pazopanib + Isoproterenol
|
DCXZGA7
|
Pazopanib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
PF-02545920 + Isoproterenol
|
DCPW1O3
|
PF-02545920
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Pinacidil + Isoproterenol
|
DCD0FID
|
Pinacidil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Pyrazinamide + Isoproterenol
|
DC908LT
|
Pyrazinamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Ramelteon + Isoproterenol
|
DCH3RPB
|
Ramelteon
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Terameprocol + Isoproterenol
|
DCMZWCF
|
Terameprocol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Terazosin + Isoproterenol
|
DCBOAE9
|
Terazosin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Tetracycline + Isoproterenol
|
DCZ03MW
|
Tetracycline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Tiagabine + Isoproterenol
|
DCVU8PH
|
Tiagabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Triiodothyronine + Isoproterenol
|
DCXM5OW
|
Triiodothyronine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
Vinblastine + Isoproterenol
|
DCXTKO4
|
Vinblastine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
VR-776 + Isoproterenol
|
DC5LGD1
|
VR-776
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
WAY-100635 + Isoproterenol
|
DCZWTHU
|
WAY-100635
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[4] |
------------------------------------------------------------------------------------ |
|
|
|
|